A citation-based method for searching scientific literature

Richard G Moore, D Scott McMeekin, Amy K Brown, Paul DiSilvestro, M Craig Miller, W Jeffrey Allard, Walter Gajewski, Robert Kurman, Robert C Bast, Steven J Skates. Gynecol Oncol 2009
Times Cited: 469







List of co-cited articles
636 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
Richard G Moore, Amy K Brown, M Craig Miller, Steven Skates, W Jeffrey Allard, Thorsten Verch, Margaret Steinhoff, Geralyn Messerlian, Paul DiSilvestro, C O Granai,[...]. Gynecol Oncol 2008
416
29

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
472
23

Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass.
Richard G Moore, M Craig Miller, Paul Disilvestro, Lisa M Landrum, Walter Gajewski, John J Ball, Steven J Skates. Obstet Gynecol 2011
150
22

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.
T Van Gorp, I Cadron, E Despierre, A Daemen, K Leunen, F Amant, D Timmerman, B De Moor, I Vergote. Br J Cancer 2011
195
19

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter, Jeffrey A Ledbetter, Michèl Schummer, Martin McIntosh, Charles Drescher, Nicole Urban, Karl Erik Hellström. Cancer Res 2003
466
18

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.
Richard G Moore, Moune Jabre-Raughley, Amy K Brown, Katina M Robison, M Craig Miller, W Jeffery Allard, Robert J Kurman, Robert C Bast, Steven J Skates. Am J Obstet Gynecol 2010
161
17

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
712
16

Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis.
E M J Meys, J Kaijser, R F P M Kruitwagen, B F M Slangen, B Van Calster, B Aertgeerts, J Y Verbakel, D Timmerman, T Van Gorp. Eur J Cancer 2016
78
19

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
957
15

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
Ronny Drapkin, Hans Henning von Horsten, Yafang Lin, Samuel C Mok, Christopher P Crum, William R Welch, Jonathan L Hecht. Cancer Res 2005
347
14

A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
Mona A Karlsen, Estrid V S Høgdall, Ib J Christensen, Christer Borgfeldt, Grigorios Kalapotharakos, Lenka Zdrazilova-Dubska, Josef Chovanec, Christianne A R Lok, Anna Stiekema, Irene Mutz-Dehbalaie,[...]. Gynecol Oncol 2015
47
27

Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders.
Richard G Moore, Michael Craig Miller, Margaret M Steinhoff, Steven J Skates, Karen H Lu, Geralyn Lambert-Messerlian, Robert C Bast. Am J Obstet Gynecol 2012
82
15

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
13

Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.
Robert L Coleman, Thomas J Herzog, Daniel W Chan, Donald G Munroe, Todd C Pappas, Alan Smith, Zhen Zhang, Judith Wolf. Am J Obstet Gynecol 2016
46
26

Simple ultrasound-based rules for the diagnosis of ovarian cancer.
D Timmerman, A C Testa, T Bourne, L Ameye, D Jurkovic, C Van Holsbeke, D Paladini, B Van Calster, I Vergote, S Van Huffel,[...]. Ultrasound Obstet Gynecol 2008
249
12

Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review.
Vincent Dochez, Hélène Caillon, Edouard Vaucel, Jérôme Dimet, Norbert Winer, Guillaume Ducarme. J Ovarian Res 2019
85
14

Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review.
Simona Ferraro, Federica Braga, Monica Lanzoni, Patrizia Boracchi, Elia Mario Biganzoli, Mauro Panteghini. J Clin Pathol 2013
105
11

Comprehensive analysis of HE4 expression in normal and malignant human tissues.
Mary T Galgano, Garret M Hampton, Henry F Frierson. Mod Pathol 2006
261
11

Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.
Frederick R Ueland, Christopher P Desimone, Leigh G Seamon, Rachel A Miller, Scott Goodrich, Iwona Podzielinski, Lori Sokoll, Alan Smith, John R van Nagell, Zhen Zhang. Obstet Gynecol 2011
130
11

The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
Karen K L Chan, Chi-An Chen, Joo-Hyun Nam, Kazunori Ochiai, Sarikapan Wilailak, Aw-Tar Choon, Subathra Sabaratnam, Sudarshan Hebbar, Jaganathan Sickan, Beth A Schodin,[...]. Gynecol Oncol 2013
55
18

Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis.
Jiwen Wang, Jia Gao, Hongwen Yao, Zongyong Wu, Minjie Wang, Jun Qi. Tumour Biol 2014
60
16


Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.
Ben Van Calster, Kirsten Van Hoorde, Lil Valentin, Antonia C Testa, Daniela Fischerova, Caroline Van Holsbeke, Luca Savelli, Dorella Franchi, Elisabeth Epstein, Jeroen Kaijser,[...]. BMJ 2014
149
10

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases.
Rafael Molina, Jose M Escudero, Jose M Augé, Xavier Filella, Laura Foj, Aureli Torné, Jose Lejarcegui, Jaume Pahisa. Tumour Biol 2011
101
10

Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
Fake Li, Ruxiu Tie, Kai Chang, Feng Wang, Shaoli Deng, Weiping Lu, Lili Yu, Ming Chen. BMC Cancer 2012
67
13


Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.
Brian Nolen, Liudmila Velikokhatnaya, Adele Marrangoni, Koen De Geest, Aleksey Lomakin, Robert C Bast, Anna Lokshin. Gynecol Oncol 2010
109
9

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
R C Bast, T L Klug, E St John, E Jenison, J M Niloff, H Lazarus, R S Berkowitz, T Leavitt, C T Griffiths, L Parker,[...]. N Engl J Med 1983
9

Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
Robert E Bristow, Alan Smith, Zhen Zhang, Daniel W Chan, Gillian Crutcher, Eric T Fung, Donald G Munroe. Gynecol Oncol 2013
70
12


Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysis.
Farshid Dayyani, Steffen Uhlig, Bertrand Colson, Kirsten Simon, Vinzent Rolny, David Morgenstern, Matthew Schlumbrecht. Int J Gynecol Cancer 2016
33
24

Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
Mona Aarenstrup Karlsen, Noreen Sandhu, Claus Høgdall, Ib Jarle Christensen, Lotte Nedergaard, Lene Lundvall, Svend A Engelholm, Anette T Pedersen, Dorthe Hartwell, Magnus Lydolph,[...]. Gynecol Oncol 2012
134
8

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
Vladimir Nossov, Malaika Amneus, Feng Su, Jennifer Lang, Jo Marie Tran Janco, Srinivasa T Reddy, Robin Farias-Eisner. Am J Obstet Gynecol 2008
188
8

HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm.
Giuseppina Ruggeri, Elisabetta Bandiera, Laura Zanotti, Silvana Belloli, Antonella Ravaggi, Chiara Romani, Eliana Bignotti, Renata A Tassi, Germana Tognon, Claudio Galli,[...]. Clin Chim Acta 2011
74
10

Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.
György Sölétormos, Michael J Duffy, Suher Othman Abu Hassan, René H M Verheijen, Bengt Tholander, Robert C Bast, Katja N Gaarenstroom, Catharine M Sturgeon, Johannes M Bonfrer, Per Hyltoft Petersen,[...]. Int J Gynecol Cancer 2016
101
8

Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management.
Elisabetta Bandiera, Chiara Romani, Claudia Specchia, Laura Zanotti, Claudio Galli, Giuseppina Ruggeri, Germana Tognon, Eliana Bignotti, Renata A Tassi, Franco Odicino,[...]. Cancer Epidemiol Biomarkers Prev 2011
89
8

Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass.
Karolina Partheen, Björg Kristjansdottir, Karin Sundfeldt. J Gynecol Oncol 2011
53
15

Reactivity of a monoclonal antibody with human ovarian carcinoma.
R C Bast, M Feeney, H Lazarus, L M Nadler, R B Colvin, R C Knapp. J Clin Invest 1981
8

Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.
Jeroen Kaijser, Ahmad Sayasneh, Kirsten Van Hoorde, Sadaf Ghaem-Maghami, Tom Bourne, Dirk Timmerman, Ben Van Calster. Hum Reprod Update 2014
97
8

Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age.
Richard G Moore, Michael Craig Miller, Elizabeth E Eklund, Karen H Lu, Robert C Bast, Geralyn Lambert-Messerlian. Am J Obstet Gynecol 2012
89
8

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.
Toon Van Gorp, Joan Veldman, Ben Van Calster, Isabelle Cadron, Karin Leunen, Frederic Amant, Dirk Timmerman, Ignace Vergote. Eur J Cancer 2012
73
10


Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
Xinliang Chen, Hui Zhou, Rui Chen, Jian He, Ying Wang, Lisi Huang, Longqiaozi Sun, Chaohui Duan, Xiaohong Luo, Haiyan Yan. Clin Chim Acta 2015
21
33

CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use.
M J Duffy, J M Bonfrer, J Kulpa, G J S Rustin, G Soletormos, G C Torre, M K Tuxen, M Zwirner. Int J Gynecol Cancer 2005
189
7

The role of biomarkers in the management of epithelial ovarian cancer.
Wei-Lei Yang, Zhen Lu, Robert C Bast. Expert Rev Mol Diagn 2017
52
13

Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses.
S Tingulstad, B Hagen, F E Skjeldestad, M Onsrud, T Kiserud, T Halvorsen, K Nustad. Br J Obstet Gynaecol 1996
191
7


The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
Martina Montagnana, Elisa Danese, Orazio Ruzzenente, Valentina Bresciani, Teresita Nuzzo, Matteo Gelati, Gian Luca Salvagno, Massimo Franchi, Giuseppe Lippi, Gian Cesare Guidi. Clin Chem Lab Med 2011
121
7

Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population.
Yong Man Kim, Dong Hee Whang, Joonseok Park, Sung Hoon Kim, Shin Wha Lee, Hyun Ah Park, Mina Ha, Kyung-Hwa Choi. Clin Chem Lab Med 2011
64
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.